Search filters

List of works by Jae-Cheol Jo

A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma

scientific article published on 29 July 2019

Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

scientific article published on 17 April 2020

Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas

scientific article published on 17 November 2020

Chronic Hepatitis B Viral Activity Enough to Take Antiviral Drug Could Predict the Survival Rate in Malignant Lymphoma

scientific article published in 2022

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

scientific article published on 18 December 2019

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

scientific article published on 04 December 2020

Radotinib inhibits mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression

scientific article published on 01 May 2019

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death.

scientific article published on 10 November 2017

The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)

scientific article published on 23 December 2019